{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T05:06:40Z","timestamp":1732597600325,"version":"3.28.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,25]]},"DOI":"10.7759\/cureus.74384","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:44:22Z","timestamp":1732527862000},"source":"Crossref","is-referenced-by-count":0,"title":["Aspirin-Exacerbated Respiratory Disease Complicated by Eosinophilic Esophagitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Eiichi","family":"Kakehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-015-0489-z","article-title":"The practice guidelines for primary care of acute abdomen 2015","volume":"34","author":"Mayumi T","year":"2016","unstructured":"Mayumi T, Yoshida M, Tazuma S, et al.. The practice guidelines for primary care of acute abdomen 2015. Jpn J Radiol. 2016, 34:80-115. 10.1007\/s11604-015-0489-z","journal-title":"Jpn J Radiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White AA","year":"2018","unstructured":"White AA, Stevenson DD. Aspirin-exacerbated respiratory disease. N Engl J Med. 2018, 379:1060-70. 10.1056\/NEJMra1712125","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE Conference","volume":"155","author":"Dellon ES","year":"2018","unstructured":"Dellon ES, Liacouras CA, Molina-Infante J, et al.. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018, 155:1022-1033.e10. 10.1053\/j.gastro.2018.07.009","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-020-01701-y","article-title":"Symptom-based diagnostic approach for eosinophilic esophagitis","volume":"55","author":"Fujiwara Y","year":"2020","unstructured":"Fujiwara Y. Symptom-based diagnostic approach for eosinophilic esophagitis. J Gastroenterol. 2020, 55:833-45. 10.1007\/s00535-020-01701-y","journal-title":"J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.110.4.1117","article-title":"Chest pain in an aspirin-sensitive asthmatic patient: Eosinophilic esophagitis causing esophageal dysmotility","volume":"110","author":"Hempel SL","year":"1996","unstructured":"Hempel SL, Elliott DE. Chest pain in an aspirin-sensitive asthmatic patient: Eosinophilic esophagitis causing esophageal dysmotility. Chest. 1996, 110:1117-20. 10.1378\/chest.110.4.1117","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2016.10.018","article-title":"Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease","volume":"118","author":"Pelletier T","year":"2017","unstructured":"Pelletier T, Tamayev R, Iammatteo M, Nautsch D, Hudes G, Lukin D, Jerschow E. Eosinophilic esophagitis as possible complication of aspirin treatment in patient with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2017, 118:120-2. 10.1016\/j.anai.2016.10.018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.09.012","article-title":"A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease","volume":"7","author":"Eid RC","year":"2019","unstructured":"Eid RC, Palumbo ML, Laidlaw TM, Buchheit KM, Cahill KN. A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2019, 7:1338-40. 10.1016\/j.jaip.2018.09.012","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro A","year":"2022","unstructured":"Muraro A, Worm M, Alviani C, et al.. EAACI guidelines: Anaphylaxis (2021 update). Allergy. 2022, 77:357-77. 10.1111\/all.15032","journal-title":"Allergy"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2019.05.001","article-title":"Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD","volume":"68","author":"Taniguchi M","year":"2019","unstructured":"Taniguchi M, Mitsui C, Hayashi H, et al.. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD. Allergol Int. 2019, 68:289-95. 10.1016\/j.alit.2019.05.001","journal-title":"Allergol Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.71","article-title":"ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE)","volume":"108","author":"Dellon ES","year":"2013","unstructured":"Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013, 108:679-92. 10.1038\/ajg.2013.71","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(95)70290-3","article-title":"Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects","volume":"96","author":"Settipane RA","year":"1995","unstructured":"Settipane RA, Schrank PJ, Simon RA, Mathison DA, Christiansen SC, Stevenson DD. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995, 96:480-5. 10.1016\/s0091-6749(95)70290-3","journal-title":"J Allergy Clin Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek G","year":"2014","unstructured":"Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014, 133:98-103.e1-6. 10.1016\/j.jaci.2013.07.004","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-015-0569-2","article-title":"Aspirin-exacerbated diseases: Advances in asthma with nasal polyposis, urticaria, angioedema, and anaphylaxis","volume":"15","author":"Stevens W","year":"2015","unstructured":"Stevens W, Buchheit K, Cahill KN. Aspirin-exacerbated diseases: Advances in asthma with nasal polyposis, urticaria, angioedema, and anaphylaxis. Curr Allergy Asthma Rep. 2015, 15:69. 10.1007\/s11882-015-0569-2","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.11-RA-0403","article-title":"Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites","volume":"61","author":"Higashi N","year":"2012","unstructured":"Higashi N, Taniguchi M, Mita H, Yamaguchi H, Ono E, Akiyama K. Aspirin-intolerant asthma (AIA) assessment using the urinary biomarkers, leukotriene E4 (LTE4) and prostaglandin D2 (PGD2) metabolites. Allergol Int. 2012, 61:393-403. 10.2332\/allergolint.11-RA-0403","journal-title":"Allergol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.10.020","article-title":"Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease","volume":"137","author":"Buchheit KM","year":"2016","unstructured":"Buchheit KM, Cahill KN, Katz HR, et al.. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016, 137:1566-1576.e5. 10.1016\/j.jaci.2015.10.020","journal-title":"J Allergy Clin Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12118","article-title":"Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus","volume":"27","author":"Zhang S","year":"2014","unstructured":"Zhang S, Wu X, Yu S. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus. Dis Esophagus. 2014, 27:601-6. 10.1111\/dote.12118","journal-title":"Dis Esophagus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI26679","article-title":"Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis","volume":"116","author":"Blanchard C","year":"2006","unstructured":"Blanchard C, Wang N, Stringer KF, et al.. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006, 116:536-47. 10.1172\/JCI26679","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-012-0640-x","article-title":"Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis","volume":"48","author":"Kinoshita Y","year":"2013","unstructured":"Kinoshita Y, Furuta K, Ishimaura N, et al.. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol. 2013, 48:333-9. 10.1007\/s00535-012-0640-x","journal-title":"J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno MP","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002, 89:474-8. 10.1016\/S1081-1206(10)62084-4","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2016.8.4.298","article-title":"Update on the management of aspirin-exacerbated respiratory disease","volume":"8","author":"Buchheit KM","year":"2016","unstructured":"Buchheit KM, Laidlaw TM. Update on the management of aspirin-exacerbated respiratory disease. Allergy Asthma Immunol Res. 2016, 8:298-304. 10.4168\/aair.2016.8.4.298","journal-title":"Allergy Asthma Immunol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319239-aspirin-exacerbated-respiratory-disease-complicated-by-eosinophilic-esophagitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T09:44:23Z","timestamp":1732527863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319239-aspirin-exacerbated-respiratory-disease-complicated-by-eosinophilic-esophagitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.74384","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,25]]}}}